Chinese medicine stocks led the decline in the opening, and Huasen pharmaceutical once hit the limit
As of press time, Chinese medicine stocks led the decline in the opening, Huasen pharmaceutical once hit the limit, and Jiyao holdings, Yiling pharmaceutical, Zhongsheng pharmaceutical, Xintian pharmaceutical and Qianjin pharmaceutical followed the decline.
This text is a result of machine translation.
Related companies：
Briefing Mar 10, 2022 03:38 PM
· Automotive
The business scope of Evergrande automobile new company includes online car Hailing service
In-depth
Automotive
Roundup: Chinese New Energy Products Shined at CES 2023
As Chinese new energy products have become the highlight of CES 2023, we at EqualOcean tracked and summarized new energy products focusing on energy storage solutions and electric bicycles from China, which are absolutely worth noticing.
Jan 24, 2023 03:19 PM
Briefing Jan 13, 2022 03:19 PM
· Automotive
Haitong strategy: domestic infrastructure policy is expected to be strengthened this year
Jan 06, 2023 08:30 AM
Nov 16, 2022 05:19 PM
Nov 08, 2022 08:32 AM
Nov 07, 2022 04:27 PM
Survey: if the climate situation is not improved, six major cities in the world may sink before 2030
Briefing Oct 07, 2021 06:33 PM
· Automotive
Zhongyu group: investing in Evergrande notes and Evergrande auto shares will produce significant losses
Briefing Sep 29, 2021 10:11 AM
· Technology
"Paixun intelligence" announced the completion of tens of millions of yuan pre-A + round of financing
Briefing Sep 26, 2021 08:00 PM
· Automotive
Evergrande Motor announced on the Hong Kong stock exchange that the proposed issuance of RMB shares will not continue.
Briefing Sep 16, 2021 10:31 AM
· Automotive
Chevron CEO: natural gas and oil prices will be quite strong in the foreseeable future
See more
Read next
Insight
In-depth
Insight
In-depth